1 year return (CAGR)
177.39%
Nurix Therapeutics Inc Exchange (NASDAQ, USD)
NRIX
25.15
+0.42 (+1.67%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
41.65%
5 year return (CAGR)
-5.10%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.65B
Price/Sales
72.04
Ent value
2.71B
Price/Book
6.58
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
2.04%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 25.01 |
| Daily high | 26.14 |
| Daily low | 24.99 |
| Daily Volume | 1.33M |
| All-time high | 50.17 |
| 1y analyst estimate | 33.93 |
| Beta | 1.79 |
| EPS (TTM) | -3.07 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 14 Apr 2026 |
Downside potential
Loading...
Downside potential data
| NRIX | S&P500 | |
| Current price drop from All-time high | -49.87% | -3.06% |
| Highest price drop | -91.53% | -56.47% |
| Date of highest drop | 25 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -61.17% | -10.68% |
| Avg time to new high | 73 days | 12 days |
| Max time to new high | 1420 days | 1805 days |
News
